Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

View:
Post by junior22 on May 18, 2016 10:32am

Brexit

With the Brexit vote date quickly approaching, I am surprised that no one has commented in awhile on the possible impact on the Companys revenues, share price and buyout, if as a result of a vote to quit the European Union, the British pound falls sharply. My understanding is that the vote will be very close. I would appreciate your comments.
Comment by cashflow98 on May 18, 2016 10:57am
Never say never but I don't think Brexit is in the cards.  There's too much to loose economically for UK citizens.  Big marketing push going on in UK to STAY in EU.   I have been tracking the polls, here is the latest news piece on the matter.  My understanding is that operationally CXR will be fine.  Optically, a stronger GBP makes our numbers look ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities